RECORDATORIO: Nuestro equipo de la línea de atención telefónica está trabajando a distancia y centrando su tiempo en ayudar a nuestros pacientes. Agradecemos a las farmacias, a los proveedores y a su personal que utilicen nuestros Portales de Farmacia y de Proveedores. Por favor, tenga en cuenta que si se pone en contacto con nosotros sobre un pago o una subvención, es más rápido enviarnos un correo electrónico a [email protected]. Le agradecemos su paciencia y esperamos seguir sirviéndole. Les deseamos a todos seguridad y buena salud durante estos momentos difíciles. El equipo de HealthWell
Degeneración Macular y Enfermedades Vasculares de la Retina
Status
Closed
Closed Funds
This fund is temporarily closed to new patients due to lack of sufficient funding. Please continue to visit our Disease Funds page often, as replenished funds reopen as quickly as possible. If you currently have a grant with HealthWell, your grant will remain active for the entire 12 month grant cycle or until you have exhausted your allocated grant amount, whichever comes first. You can continue to use your pharmacy card or submit requests for reimbursements during your designated grant cycle.
Assistance Type
Prescription Drug Copayor
Insurance premium (Medicare Part B only)
Maximum Award Level
Payment Type
Pharmacy CardMinimum Copay Reimbursement Amount
Minimum Copay Reimbursement Amount
We encourage you to please use your HealthWell pharmacy card for any applicable charges as possible.
Minimum Premium Reimbursement Amount
Household Income Limit
500% of the Federal Poverty Level(adjusted for household size and high cost of living areas)
Treatments Covered
- Abrilada Pen
- Abrilada Pfs
- Acetazolamide
- Acular
- Acuvail
- Adalimumab
- Adalimumab-aacf Pen
- Adalimumab-aacf Pfs
- Adalimumab-aaty
- Adalimumab-adaz
- Adalimumab-adbm
- Adalimumab-afzb
- Adalimumab-aqvh
- Adalimumab-atto
- Adalimumab-bwwd
- Adalimumab-fkjp
- Adalimumab-ryvk
- Aflibercept
- Aflibercept-ayyh
- Alymsys
- Amjevita Pfs
- Amjevita Sureclick Autoinjector
- Ascorbic Acid
- Avacincaptad Pegol
- Avacincaptad Pegol Sodium
- Avastin
- Beovu
- Beovu Pfs
- Beta Carotene
- Bevacizumab
- Bevacizumab-adcd
- Bevacizumab-awwb
- Bevacizumab-bvzr
- Bevacizumab-maly
- Bevacizumab-nwgd
- Brolucizumab-dbll
- Byooviz
- Captopril
- Cimerli
- Cyltezo Pen
- Cyltezo Pfs
- Dexamethasone
- Dextenza
- Dexycu
- Empaveli
- Eylea
- Eylea Hd
- Eylea Pfs
- Faricimab-svoa
- Fluocinolone Acetonide
- Hadlima Pfs
- Hadlima Pushtouch Autoinjector
- Hemangeol
- Hulio Pen
- Hulio Pfs
- Humira Pen
- Humira Pfs
- Hyrimoz Pen
- Hyrimoz Pfs
- Iluvien
- Inderal La
- Innopran Xl
- Izervay
- Jobevne
- Ketorolac Tromethamine
- Lisinopril
- Lucentis
- Mannitol
- Maxidex
- Mvasi
- Natural Mixed Tocopherols
- Osmitrol
- Ozurdex
- Pavblu
- Pavblu Pfs
- Pegcetacoplan
- Pentoxifylline
- Propranolol Hcl
- Qbrelis
- Ranibizumab
- Ranibizumab-eqrn
- Ranibizumab-nuna
- Retisert
- Simlandi Autoinjector
- Simlandi Pfs
- Susvimo
- Syfovre
- Thalomid
- Triamcinolone Acetonide
- Triesence
- Vabysmo
- Vabysmo Pfs
- Vegzelma
- Verteporfin
- Visudyne
- Vitamin E (non Otc)
- Xipere
- Yuflyma Autoinjector
- Yuflyma Pfs
- Yusimry Pen
- Zestril
- Zirabev
Fund Definition
Assistance with the prescription drugs and biologics used in the treatment of AMD and Retinal Vascular Diseases.
Grant Utilization
HealthWell estimates that patients use an average of $1,500 during their 12-month grant period for this disease area.
Do I Qualify?
HealthWell bases eligibility on an individual’s medical, financial and insurance situation. To qualify for HealthWell’s assistance, applicants must meet the following eligibility requirements:
-
Please make sure that HealthWell currently has a fund for your diagnosis/indication and that your medication is covered under that fund by visiting our Disease Funds listing. If we do not have a fund that currently covers your diagnosis, please check back as we frequently open and reopen programs as funding becomes available. The Foundation is able to help patients receiving treatment for indications for which we currently have an open fund. We can only assist with medications that have been prescribed to treat the disease/covered diagnosis. You will be asked to provide the Foundation with the patient’s diagnosis, which must be verified by a physician, nurse practitioner, or physician assistant’s signature. The patient must receive treatment in the United States.
-
To qualify for copayment assistance from HealthWell, you must have some form of health insurance (private insurance, Medicare, Medicaid, TriCare, etc.) that covers part of the cost of your treatment. Please note that in order to qualify for premium assistance through this fund, you must have Medicare Part B. The Foundation will refer patients without prescription insurance to other programs, such as manufacturer patient assistance programs.
-
-
If you are receiving treatment in the U.S. and have met the eligibility criteria as listed, you are ready to apply! Please note that you will be asked to provide a Social Security Number in order to create a grant. This information is gathered to eliminate duplicate applications and is kept secure and confidential.
About AMD and Retinal Vascular Diseases
Macular Degeneration is caused by the deterioration of the central portion of the retina; the inside back layer of the eye that records the images we see and sends them via the optic nerve from the eye to the brain. The retina’s central portion, known as the macula, is responsible for focusing central vision in the eye.
Retinal vascular diseases involve abnormalities in the arteries, veins, or capillaries of the retina where normal blood flow has been disrupted, which can damage retinal tissue and impair vision. Some common types of retinal vascular disease include diabetic retinopathy, retinal vein occlusion, retinal artery occlusion, and hypertensive retinopathy. Source: American Macular Degeneration Foundation, National Eye Institute
Additional Educational Resources
You may also visit our Resource List to view other copayment organizations that may provide assistance.
